Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PCS "Encouraged" By Pricing Of COX-2 Inhibitors Close To Branded NSAIDs

Executive Summary

The recent pricing of Merck's Vioxx and Searle's Celebrex close to existing branded non-steroidal anti-inflammatory drugs is evidence of some pricing restraint in the pharmaceutical industry, PCS Health Systems CEO Jean-Pierre Millon said May 3 at The Wall Street Journal Healthcare Summit in Washington, D.C.

You may also be interested in...



Rx Re-Importation Bill Impact Could Be Limited By Canadian Export Laws

Canadian export regulations would limit the impact of pharmaceutical re-importation proposals pending in Congress, a former Canadian official said at a July 24 American Enterprise Institute conference in Washington, D.C.

Rx Re-Importation Bill Impact Could Be Limited By Canadian Export Laws

Canadian export regulations would limit the impact of pharmaceutical re-importation proposals pending in Congress, a former Canadian official said at a July 24 American Enterprise Institute conference in Washington, D.C.

Africa AIDS Drug Program Relies On NGOs To Achieve Secure Distribution

Five of the major AIDS drug marketers are counting on the leading non-governmental organizations to develop secure distribution systems for drugs supplied to developing countries.

UsernamePublicRestriction

Register

ID1122310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel